Berlin - Delayed Quote EUR
IDEXX Laboratories Inc (IX1.BE)
416.90
+4.90
+(1.19%)
As of 8:08:18 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,931,836
3,897,504
3,660,953
3,367,324
3,215,360
Cost of Revenue
1,522,600
1,518,577
1,470,983
1,362,986
1,325,928
Gross Profit
2,409,236
2,378,927
2,189,970
2,004,338
1,889,432
Operating Expense
1,263,323
1,250,590
1,092,842
1,105,573
957,404
Operating Income
1,145,913
1,128,337
1,097,128
898,765
932,028
Net Non Operating Interest Income Expense
-21,477
-18,506
-35,952
-38,793
-29,374
Pretax Income
1,124,436
1,109,831
1,061,176
859,972
902,654
Tax Provision
229,471
221,964
216,134
180,883
157,810
Net Income Common Stockholders
894,965
887,867
845,042
679,089
744,845
Diluted NI Available to Com Stockholders
894,965
887,867
845,042
679,089
744,845
Basic EPS
10.91
10.77
10.17
8.12
8.74
Diluted EPS
10.82
10.67
10.06
8.03
8.60
Basic Average Shares
82,022.75
82,467
83,066
83,623
85,200
Diluted Average Shares
82,737.25
83,246
83,978
84,600
86,572
Total Operating Income as Reported
1,145,913
1,128,337
1,097,128
898,765
932,028
Total Expenses
2,785,923
2,769,167
2,563,825
2,468,559
2,283,332
Net Income from Continuing & Discontinued Operation
894,965
887,867
845,042
679,089
744,845
Normalized Income
894,965
887,867
845,042
679,089
744,845
Interest Income
9,483
12,699
5,629
1,065
434
Interest Expense
30,960
31,205
41,581
39,858
29,808
Net Interest Income
-21,477
-18,506
-35,952
-38,793
-29,374
EBIT
1,155,396
1,141,036
1,102,757
899,830
932,462
EBITDA
1,289,491
1,270,972
1,217,665
1,011,730
1,037,058
Reconciled Cost of Revenue
1,522,600
1,518,577
1,470,983
1,362,986
1,325,928
Reconciled Depreciation
134,095
129,936
114,908
111,900
104,596
Net Income from Continuing Operation Net Minority Interest
894,965
887,867
845,042
679,089
744,845
Normalized EBITDA
1,289,491
1,270,972
1,217,665
1,011,730
1,037,058
Tax Rate for Calcs
0
0
0
0
0
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade